Opinion

The Build Back Better plan, if it passes the Senate, could provide billions of dollars for climate tech start-ups. Brad Harrison of Scout Ventures in Austin is thus bullish on seed investing.

Jason Schoettler of Calibrate Ventures talks about the potential for growth in healthtech and how it's attracting plenty of venture investors with their eyes on the $800bn US healthcare industry.

Amit Anand of Jungle Ventures peers behind the curtain of Southeast Asia and calls it the world’s next great digital economy hub.

Issac Roth of Shasta Ventures looks ahead to the new year. He says the new presidential administration won't much impact tech. He also sees trends with firm specialization and synthetic biology.

Bernard Ross of Sky Medical Technology says that the European medtech market has grown in recent years and he expects it to keep rising since the region is ripe with innovation.

Matt McCooe of Connecticut Innovations writes that the stereotypical successful tech entrepreneur is not a nerdy white guy in jeans from Silicon Valley. Investors need to broaden their lens.

The Commission's exemption allowing finders to engage broker-dealer-like activities could impact venture scouts.

It's not just business as usual for investors; many are seeing an uptick in activity as this has the feel of the busiest fall season in memory.

Tom Walker of Rev1 Ventures addresses the question of whether investors should back biotech start-ups that focus on the coronavirus and other potential pandemics. Here's what you should know.